Tag | Content |
---|
EnhancerAtlas ID | HS018-23422 |
Organism | Homo sapiens |
Tissue/cell | CD19+ |
Coordinate | chr9:33116110-33118850 |
SNPs | Number: 3 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EWSR1-FLI1 | MA0149.1 | chr9:33118817-33118835 | TAAAGCAAGGAAGGAAAG | + | 6.04 | FOSL2 | MA0478.1 | chr9:33117771-33117782 | CTGAGTCATCC | - | 6.32 | IRF1 | MA0050.2 | chr9:33118670-33118691 | AAAATAAAAGAAAAAGAAAAA | - | 6.27 | JUNB | MA0490.1 | chr9:33117771-33117782 | CTGAGTCATCC | - | 6.14 | NFE2L1 | MA0089.2 | chr9:33117767-33117782 | GGTGCTGAGTCATCC | - | 6.54 | Nfe2l2 | MA0150.2 | chr9:33117769-33117784 | TGCTGAGTCATCCAC | - | 6.39 | Nr2f6(var.2) | MA0728.1 | chr9:33116440-33116455 | TGATCTCTTAACCTC | - | 6.32 | Zfx | MA0146.2 | chr9:33117007-33117021 | CAGGCCTAGGCCCA | - | 6.22 | Zfx | MA0146.2 | chr9:33116463-33116477 | CCGGCCTCGGCCTC | + | 6.28 |
|
| Number of super-enhancer constituents: 18 | ID | Coordinate | Tissue/cell |
SE_09459 | chr9:33116500-33118547 | CD14 | SE_10229 | chr9:33116646-33118202 | CD19_Primary | SE_10912 | chr9:33108749-33119337 | CD20 | SE_18665 | chr9:33116636-33118720 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19329 | chr9:33116913-33117956 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20045 | chr9:33116707-33118279 | CD56 | SE_22416 | chr9:33116772-33118265 | CD8_primiary | SE_26031 | chr9:33116732-33117694 | Duodenum_Smooth_Muscle | SE_29800 | chr9:33116657-33118405 | Fetal_Muscle | SE_35029 | chr9:33117507-33118594 | HeLa | SE_40894 | chr9:33116811-33117517 | Left_Ventricle | SE_42236 | chr9:33116764-33117349 | Lung | SE_44340 | chr9:33116602-33118379 | NHDF-Ad | SE_45731 | chr9:33116607-33118503 | Osteoblasts | SE_53402 | chr9:33116921-33117416 | Spleen | SE_53402 | chr9:33117660-33118346 | Spleen | SE_62118 | chr9:33106994-33169093 | Toledo | SE_62346 | chr9:33106942-33169226 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr9 | 33117939 | 33118087 | chr9 | 33116788 | 33117885 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH09I033116 | chr9 | 33116610 | 33118219 |
|
Enhancer Sequence | GCTGGAGGAA AAACATACAC ACAGAAGGAG CAGTGGTTAG TTAAGTTCTG ACATCCCCAA 60 AATAAAGCTT GCTGAGAACA TAAACACTTT TAAAGTTATT CTTTTTGCTT CTCTAGAGTT 120 TTTATTTATT TTTTTTTTGA GACGTAGTCT TGCTCTGTTG CCAGGCTGGA GTGCAGGGGC 180 GCGATCTAGG CTCACTGCAA CTTCCGCCTC CCGGGTTCAA GCGATTCTTC TGCCTCAGCC 240 TCCTGAGGAG CTGGGACTAC AGGCGCCTGC CACCACGCCC AGCTAATTTT TAGTAGAGAC 300 AGGGTTTCAC CATGTTGGTC AGGATGGTCT TGATCTCTTA ACCTCGTGAT CCACCGGCCT 360 CGGCCTCCCA AAGTGCTGGG ATTACAGTTG TAAGACACCA AACCGGATCT TTTTTTTTTT 420 TTTTTTTTGA AGGAGTCTCG CTCTGTAGCC CAGGCTGGAG TACAATGGCG TGATCTCGGC 480 TCACTGCAAC CTCCGCCTCC CAGGTTTTCA AGTAATTCTC CTGTCTCAGC CTCCCAAGTA 540 GCTGGGACTA CAGGCGTGTG CCACCACACC TGGCTAATTT TTGTATTTTT AGTACAGATG 600 GGGTTTCACC ATATTGGTCA GGCTGGTCTC GAACTCCTGA CCTCAGGTGA TCCACCCACC 660 TTAGCCTCCC AAAGTGCTGG GATCACAGGC AAGAGCCACC ATGTCCAGCC TCTCTAAAGC 720 TTTTTTGATG GTGGGTGGGG TGGGAGGGAG CAGTTACAAG GGTTTTGTCT GTTTTGCTTT 780 TCTATCAGGG CTCAGATGAC CTTAAATTAG ACACAGATAT CAAAAAGTAT GATCTTCCTC 840 TTTCTACAAC ACAGTGCTGT TTCTGTGGTT ATGTAGAAAG CCAGTCAGTG ACAAGAGCAG 900 GCCTAGGCCC AGTTCTTCCT GAGTGGCTCA GGAATCTGCT TCTCCTGTGC TCTGTTCCCG 960 CACATGAAGT CCTTATCCAG GAACTCCTGG AATCTGAGAT TGTTTCAGAG CCTCTCTGTA 1020 CCCACCCAGT CACAGCCCCC CTTCCACACC CATCCTATCG ACCAATCCAG CTTTCATGCT 1080 TCCAAAGGCA TACTGACTAG AACACTGGCC CTAACAGTTG AGGCAGTGTT TCTGAAAATT 1140 TGCTAAAATA AAACTTCTTT GAAACTTCAG ACTTTATCCT GATTTAGCAA AATGTATAAT 1200 GATGAACTTA TGTTTTAACA TATTTTCAAG TAGTAGAGCA TCTGGGCTCT CATCCTTCCA 1260 AAACTTTTTG TATTTTAATA TTTCAGTGGT TATGAATTGT GAACTCCTAA GGGATACAAA 1320 GTCAGCACTG ATGAGAAATG TCAAGAATCA GGACGTGCCC CAAAGCCTTC CTGTGGGTTC 1380 TCTAAAGGCT GTGGTTTTGT GTGACTCTGA GTGCAGCTCC AAACCACACC CAGCTCTTTC 1440 TGGAATCCAA AAAGACCAAA CCCATCACAT AAATTAAGGA AAACTCTAAC TCAGACTTTG 1500 AGGGGGAAGT CAGCCAAACC ATACAGAACA TATGAAAATA AAGATGCAAT TATTATTTTC 1560 AAATATATTC AGGAATTCTG ACTGTAAGGA TCCTCAAGCA AAGGTCCCCA GGGGGTCTGC 1620 TTTAATGAAC CTATTCGTAA TTAGGTGTCA TCACTTAGGT GCTGAGTCAT CCACCTTTGG 1680 CACACCTCAT ACTACTGTCC ACATTATTAA TGTGAGGGTT TGAACCAAAG GTGGCCAGGC 1740 CAATAAGGTT TTCTGATAAT CAGTGCTTTT ACAGAAATGG ATTCTTAGCT ATTTCAGAGG 1800 GAAGTACATG CCAAGCTGAC ATGATTTGGT TTTGCTGTCT CTGCTGCTTT CTCTCCCCTA 1860 TCTGCCCCAA GCCCAAACCT GCCAGGCTCC TTGTGAAACA AACATGGTGC TGTGGCAAAG 1920 AATTAGGGCA TCACGGGCCC CTTCCTTGTT CACCACTGTG CTTCAAGGGA TGAATCAAGA 1980 GGGGTCAGGG TATAAACCTG TGTGTTTCAA GAGAAGAAGA TACACACACG GAGAGGGAGG 2040 AAGGGTGAAA GCGGGGACGG AAGGGTATAG AAGGATTTCT GAAGAGTCTA AAAGTAAGGT 2100 TACATTCAAA TTTTCCTCCC TTTAAGACAA GAAGTTAGGA TTTTTGATCT GGGAGAAGGA 2160 CTTCATACAT TCCTATATTC CCATCACAGC TCTCATGCTC CCAGCAAGGG AGGACAGGAA 2220 GAAATGATGA GAATAAAATG AGTCTGACAG AAAGCTGTTG CATCTCAGCA GGTGCAGTAG 2280 TTCATGCCTG TCATCCCAGC ACTTTGGGAG GTCAAAGCAG GAGGATTGCT TGAGCCCCCA 2340 GGAGTTCAAG ACCAGCCTGG GTAACATAGT GAGACATCTC TAAAAAAAAA AATTTTTTTT 2400 TTTTTAAATC AGCCAGGGGT GCTGGCCCAC ACCTGTGGTC CCAGCTACTA GGAAAGCCGA 2460 GGTGAGAGGA TCACTTGAGC CAGGGAGTTT AAGGCTATAG TGAGCCATGA TCACGCCACT 2520 GCACTCCAGG CTGGGTGACA AGCAAGACTC TGTCTCAAAA AAAATAAAAG AAAAAGAAAA 2580 AAAGTTGTAT CTAAAATAAA GGGTCTGCTG TCTACATGAG CCAACCACAC TGTACTAGTC 2640 AGCCTAAACC AGGGGTACCC AACATAGAGG GTACCTGCAG CACAGCTCCT GGATCTTCAG 2700 ATTCACTTAA AGCAAGGAAG GAAAGGGTTT TGTTATTCAA 2740
|